Review
Copyright ©The Author(s) 2022.
World J Gastroenterol. Nov 28, 2022; 28(44): 6213-6229
Published online Nov 28, 2022. doi: 10.3748/wjg.v28.i44.6213
Table 2 Intestinal flora regulation in primary sclerosing cholangitis treatment
Treatment
Results
Ref.       
Oral AntibioticsVancomycin125 mg four times daily for 90 dFecal calprotectin and serum GGT levels returned to normal[94]
125 mg four times daily for 12 wkSignificantly decreased ALP, MRS, ESR, and GGT levels. Fatigue, pruritus, diarrhea, and anorexia significantly improved[91]
50 mg/kg/d for 30 to 118 moDecreased ALT, AST, GGT, and ESR levels. Jaundice improved. The overall rate of positive serum autoantibodies decreased after 3.5 mo[138]
Vancomycin and metronidazoleVancomycin: 125 mg or 250 mg four times daily for 12 wk; Metronidazole: 250 mg or 500 mg three times daily for 12 wkDecreased ALP and MRS levels. The decrease in ALP level was more pronounced following vancomycin administration[90]
Metronidazole with ursodeoxycholic acidTaken together for 36 moSignificantly decreased ALP and MRS levels[98]
Azithromycin500 mg three days per week for 6 wkDecreased ALP and TBIL levels and cholestasis-related symptoms. The urine was turned dark in color again[139]
Rifaximin550 mg twice daily for 12 wkDecreased GGT and CRP levels; Improved pruritus symptoms[95]
Minocycline100 mg twice daily for one yearSignificantly decreased ALP and MRS levels[100]
Fecal microbiota transplantation at 24 wkSignificantly decreased ALP levels; Reduced AST levels (by at least 30%)[107]
ProbioticsLactobacilli and BifidobacteriaThree months of: Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus salivarius, and Lactococcus lactis, Bifidobacterium bifidum, BifidobacteriumReduced ALP levels (by 15%)[113]
CombinedPrednisolone (30 mg/d), salazosulfapyridine (3000 mg/d), and Lactobacillus casei Shirota (3 g/d) for 2 wkDecreased ALP, ALT, AST, and GGT levels[114]